Early Treatment with Faricimab Stops Vision Loss in Wet Macular Degeneration
Faricimab is a newer eye medicine that fights wet age‑related macular degeneration, a leading cause of blindness. Researchers in Wales studied people who had never been treated before. They split the patients into two groups: those whose vision was still good (less than 0. 3 logMAR) and those